Finding the ‘Guilty’ Gene Variant of Sporadic Parkinson’s Disease Via CRISPR/Cas9

被引:0
|
作者
Shenzhao Lu
Jiawei Zhou
机构
[1] Chinese Academy of Sciences,Institute of Neuroscience, State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences
来源
Neuroscience Bulletin | 2017年 / 33卷
关键词
Parkinson’s disease; Genetic variant; CRISPR/Cas9;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a common neurodegenerative disorder affecting millions of people worldwide, but its cause and pathogenesis are still not fully understood. Earlier studies have shown that SNCA, which encodes α-synuclein, is one of the key genes associated with PD. Single-nucleotide polymorphism (SNP) variants of SNCA are thought to be correlated with disease onset. The underlying mechanisms however are enigmatic. A recent study published in Nature revealed that one of the SNP variants in the SNCA non-coding element elevated α-synuclein expression in human neurons by reducing the binding efficiency of transcription factors, demonstrating a previously uncharted role for SNPs in the pathogenesis of PD.
引用
收藏
页码:115 / 117
页数:2
相关论文
共 50 条
  • [31] Novel disease resistance gene paralogs created by CRISPR/Cas9 in soy
    Ervin D. Nagy
    Julia L. Stevens
    Neil Yu
    Chris S. Hubmeier
    Nona LaFaver
    Megan Gillespie
    Brian Gardunia
    Qianshun Cheng
    Steven Johnson
    Audrey L. Vaughn
    Miguel E. Vega-Sanchez
    Mingqui Deng
    Linda Rymarquis
    Richard J. Lawrence
    Graeme S. Garvey
    Robert T. Gaeta
    Plant Cell Reports, 2021, 40 : 1047 - 1058
  • [32] Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing
    Tang, Jia-Xin
    Pyle, Angela
    Taylor, Robert W.
    Olahova, Monika
    GENES, 2021, 12 (10)
  • [33] Developing zebrafish CRISPR/Cas9 knockout models of Parkinson's Disease to identify novel therapeutic targets
    Garcia-Fernandez, J.
    Lopez-Blanch, L.
    Irimia, M.
    De Santis, F.
    Terriente, J.
    MOVEMENT DISORDERS, 2022, 37 : S581 - S581
  • [34] CRISPR/Cas9 Edited sRAGE-MSCs Protect Neuronal Death in Parkinson's Disease Model
    Lee, Aesuk
    Bayarsaikhan, Delger
    Arivazhagan, Roshini
    Park, Hyejung
    Lim, Byungyoon
    Gwak, Peter
    Jeong, Goo-Bo
    Lee, Jaewon
    Byun, Kyunghee
    Lee, Bonghee
    INTERNATIONAL JOURNAL OF STEM CELLS, 2019, 12 (01) : 114 - +
  • [35] CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease
    Asmus, Natalie
    Kantor, Boris
    MOLECULAR THERAPY, 2021, 29 (04) : 415 - 415
  • [36] Expanding the CRISPR/Cas9 Toolbox for Gene Engineering in S. cerevisiae
    Ofri Levi
    Yoav Arava
    Current Microbiology, 2020, 77 : 468 - 478
  • [37] Expanding the CRISPR/Cas9 Toolbox for Gene Engineering in S. cerevisiae
    Levi, Ofri
    Arava, Yoav
    CURRENT MICROBIOLOGY, 2020, 77 (03) : 468 - 478
  • [38] Harnessing CRISPR/Cas9 technology in cardiovascular disease
    Rezaei, Hamzeh
    Khadempar, Saedeh
    Farahani, Najmeh
    Hosseingholi, Elaheh Zadeh
    Hayat, Seyed Mohammad Gheibi
    Sathyapalan, Thozhukat
    Sahebkar, Amir Hossein
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (02) : 93 - 101
  • [39] CRISPR/Cas9 Editing for Gaucher Disease Modelling
    Pavan, Eleonora
    Ormazabal, Maximiliano
    Peruzzo, Paolo
    Vaena, Emilio
    Rozenfeld, Paula
    Dardis, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [40] In vivo and in vitro disease modeling with CRISPR/Cas9
    Kato, Tomoko
    Takada, Shuji
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2017, 16 (01) : 13 - 24